BARCLAYS PLC - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 80 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$39
-9.3%
21,498
-43.5%
0.00%
Q4 2022$43
-99.9%
38,071
+33.4%
0.00%
Q3 2022$66,000
-91.9%
28,543
-89.4%
0.00%
-100.0%
Q2 2022$819,000
-73.8%
270,286
-41.2%
0.00%
-50.0%
Q1 2022$3,122,000
-74.0%
459,909
-68.0%
0.00%0.0%
Q4 2021$12,002,000
+3927.5%
1,437,238
+3480.0%
0.00%
Q3 2021$298,000
+2.8%
40,146
-5.6%
0.00%
Q2 2021$290,000
+21.3%
42,538
+82.2%
0.00%
Q1 2021$239,000
+512.8%
23,342
+319.1%
0.00%
Q4 2020$39,000
-42.6%
5,569
-33.7%
0.00%
Q3 2020$68,000
+3.0%
8,402
-11.9%
0.00%
Q2 2020$66,000
+153.8%
9,536
+70.6%
0.00%
Q1 2020$26,000
-81.9%
5,591
-66.1%
0.00%
Q4 2019$144,000
+289.2%
16,515
+51.0%
0.00%
Q3 2019$37,000
-44.8%
10,937
-19.0%
0.00%
Q2 2019$67,000
-64.6%
13,496
-55.6%
0.00%
Q1 2019$189,000
+44.3%
30,370
-22.0%
0.00%
Q4 2018$131,000
-68.4%
38,934
-39.2%
0.00%
Q3 2018$415,000
+7.2%
64,034
+26.8%
0.00%
Q2 2018$387,000
-88.9%
50,488
-67.5%
0.00%
-100.0%
Q1 2018$3,478,000
+5509.7%
155,583
+3078.4%
0.00%
Q4 2017$62,000
-16.2%
4,895
+4.2%
0.00%
Q3 2017$74,000
+105.6%
4,698
+80.3%
0.00%
Q2 2017$36,000
+16.1%
2,605
+86.1%
0.00%
Q1 2017$31,0001,4000.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
TRV GP II, LLC 9,200,349$64,402,00044.86%
TRV GP III, LLC 3,048,780$21,342,0001.83%
SILVERARC CAPITAL MANAGEMENT, LLC 406,665$2,847,0001.65%
Sofinnova Investments, Inc. 925,280$6,477,0000.39%
Omega Fund Management, LLC 334,965$2,345,0000.35%
Yorktown Management & Research Co Inc 49,200$344,0000.31%
Woodline Partners LP 940,902$6,586,0000.18%
HUSSMAN STRATEGIC ADVISORS, INC. 51,000$357,0000.09%
HORIZON FINANCIAL SERVICES, LLC 12,005$84,0000.08%
Gyon Technologies Capital Management, LP 26,893$188,0000.06%
View complete list of JOUNCE THERAPEUTICS INC shareholders